MHC Ib-restricted CD8 + T cells have been implicated in host defense against Mycobacterium tuberculosis (Mtb) infection. However, the relative contribution of various MHC Ibrestricted T cell populations to anti-mycobacterial immunity remains elusive. In this study, we used mice that lack MHC Ia ( 
Author Summary
Tuberculosis, the disease caused by Mycobacterium tuberculosis (Mtb), remains a major global health burden. As T cells are crucial to the control of Mtb infection, it is imperative to decipher the role of different T cell subsets in anti-Mtb immunity for the development of more effective vaccines. While the contribution of conventional T cells to protective
Introduction
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), remains one of the world's deadliest communicable diseases, with 1.5 million deaths annually [1] . Due to the emergence of multidrug-resistant Mtb strains, co-infection with HIV, and the failure of BCG vaccine to control adult pulmonary TB [1, 2] , there is an urgent need for new and more effective TB vaccines. However, achieving this goal relies on further investigation of the properties of protective T cells during Mtb infection [3] . It is well established that immune protection against Mtb infection is dependent on a robust Th1 response, mediated by CD4 + T cells [4] [5] [6] [7] , while CD8 + T cells are required for optimal immunity [8] [9] [10] [11] . The cytokines IL-12, IFN-γ and TNF-α are critical for the control of Mtb infection [12] . Current subunit vaccine candidates target conventional CD4 + and MHC Ia-restricted CD8 + T cells [13] . However, increasing evidence shows that unconventional T cells restricted by MHC Ib molecules can recognize distinct types of microbial antigens and may contribute to host defense against microbial infection [14, 15] . Yet, it remains unclear whether MHC Ib-restricted CD8 + T cells play a protective role during Mtb infection and which MHC Ib molecules may be involved in anti-mycobacterial immunity. MHC Ib molecules are structurally similar to MHC Ia molecules and associated with β 2 -microglobulin (β 2 m) [14] . Unlike MHC Ia molecules, MHC Ib molecules exhibit limited polymorphism, making them attractive targets for vaccine development [14, 15] . The mammalian genome encodes many MHC Ib molecules though only a few are known to have immunological function. These include H2-M3 (M3), Qa-1/HLA-E, Qa-2/HLA-G, CD1 and MHC-related gene 1 (MR1) in mice and/or humans [14] . T cells restricted by MHC Ib molecules have been implicated in host defense against Mtb in humans and mice [15] . In particular, M3-restricted CD8 + T cells recognize several N-formylated peptides derived from Mtb [16] and vaccination of mice with dendritic cells pulsed with N-formylated Mtb peptides conferred protection against Mtb in mice [17] . CD1d-restricted iNKT cells, which recognize self and/or microbial lipids [18, 19] , can be activated by Mtb-infected macrophages and lead to the control of intracellular mycobacteria through the production of GM-CSF [20, 21] . In addition, Mtb lipid-specific group 1 CD1-restricted T cells were detected in patients with active or latent TB infection [22, 23] and participated in host adaptive immune responses to Mtb in human group 1 CD1 transgenic mice [24, 25] . Recently, MR1-restricted mucosal-associated invariant T cells (MAIT), which recognize vitamin B metabolites during bacterial infection [26] , were also shown to contribute to anti-mycobacterial immunity [27, 28] . In addition, HLA-E, the human homolog of mouse Qa-1, presents Mtb-derived peptides to cytotoxic CD8 + T cells [29, 30] .
Although these MHC Ib-restricted T cells were detected or induced following immunization or infection, their relative contribution during Mtb infection has yet to be defined. Furthermore, it is unclear whether other MHC Ib molecules are involved in antigen presentation to T cells during Mtb infection. Previous studies have shown that MHC Ia-deficient mice were more resistant to Mtb infection than β 2 m-deficient mice [31, 32] . However, it is unclear whether MHC Ib-restricted CD8 + T cells contribute to the observed protection in these studies because β 2 m -/-mice have aberrant iron metabolism and impaired innate immunity aside from lacking both MHC Ia and Ib-restricted CD8 + T cells [33] . In addition, it is unclear whether M3 plays a dominant role in MHC Ib-mediated immune responses against Mtb infection, as was the case in Listeria infection [34] . In this study, we used mice that lack MHC Ia (K 
Results

Non-M3, MHC Ib-restricted CD8 + T cells contribute to protective immunity against Mtb
We have previously demonstrated that M3-restricted CD8 + T cells expanded extensively during Listeria infection and played a prominent role in host defense against Listeria [34] . To test whether M3-restricted CD8 + T cells play similar roles during Mtb aerosol infection, we first compared CD8 + T cell responses in the lungs and spleens of Mtb-infected C57BL/6 (B6), 
M3
-/-and B6 mice had comparable bacterial burden in the lungs and spleens over the course of infection (Fig 1D and 1E) , suggesting that the presence of MHC-Ib restricted T cells can compensate for the lack of MHC-Ia-restricted CD8 + T cells to control Mtb infection.
To determine whether non-M3, MHC Ib-restricted CD8 + T cells mediated the protective
-/-mice were repeatedly treated with anti-CD8β mAb or control Ab and the bacterial burden in the lungs of these two groups of mice were compared at day 30 post-infection. As shown in Fig 1F , 
-/-mice received CD8 depleting mAb or control IgG at day 28 post-infection. Data shown are the mean ± SEM from 9 mice per group. *P <0.05, **P <0.01, ***P <0.001, ns, no statistical significance. (Fig 2C and 2D ). To further address the question whether activated CD8 + T cells in
-/-mice can develop into long-lived memory precursor cells, we compared the expression of CD127, the IL-7 receptor α, on CD44
-/-and B6 mice. We found a significantly lower proportion of memory
-/-mice expressed CD127 as compared to those in B6 mice (Fig 2E-2G ). These results suggest that MHC Ib-restricted CD8 + T cells acquire a terminally differentiated phenotype during Mtb infection and most of these CD8 + T cells are short-lived effectors.
Mtb antigen stimulation induces high frequency of IFN-γ producing CD8
To compare the magnitude of Mtb antigen-specific CD8 + T cell responses in B6 and 
-/-mice produced IFN-γ in response to WCL, PPD and CFP stimulation but not total lipids (Fig 4A and 4B) . Meanwhile, when stimulated with proteinase K-treated WCL, the frequency of IFN-γ producing CD8 + T cells was reduced by more than 50% ( (Fig 4C) , suggesting that MyD88 pathway likely does not play a major role in the activation of MHC Ib-restricted CD8 + T cells.
Non-M3, MHC Ib-restricted CD8 + T cells exhibit polyfunctional characteristics
Polyfunctional T cells simultaneously producing multiple cytokines (IFN-γ, TNF-α and IL-2) have been shown to either correlate with protective immunity against Mtb [41, 42] or TB disease activity in humans [43, 44] 
Non-M3, MHC Ib-restricted CD8 + T cells recognize various Mtb protein antigens
Several immunodominant antigens recognized by Mtb-specific MHC Ia-restricted CD8 + T cells have been identified [10] . However, little is known about the Mtb antigens recognized by (Fig 6A and 6B) . The Mtb antigen-specific CD8 + T cell responses were higher in the lungs compared to the spleens, but the pattern of reactivity was similar between the organs. Among these Mtb antigen-specific MHC Ib-restricted CD8 + T cells, the frequencies of CFPand PstS1-specific CD8 + T cells were highest (Fig 6A and 6B) . In contrast, CD8 + T cells from B6 mice recognized most of these Mtb antigens at a lower frequency but exhibited strong reactivity to TB10.4 4−11 peptide (Fig 6C and 6D) . These results indicate that MHC Ia and MHC Ibrestricted CD8 + T cells recognize distinct Mtb antigens during infection. It also suggests that PstS1 might be an immunodominant antigen recognized by MHC Ib-restricted CD8 + T cells. (Fig 7A and 7B ). This suggested that most of the cytokine-producing CD8 + T cells in To substantiate this finding, we examined the cytokine production of these CD8 + T cells in response to stimulation with Mtb antigen-pulsed BMDCs derived from mice that express different levels of Qa-2, i.e. C57BL/6 (Qa-2 We found the percentage of Mtb-specific IFN-γ-producing CD8 + T cells was higher when CD8 + T cells were co-cultured with BMDCs from C57BL/6 than from BALB/cJ mice and almost undetectable when stimulated with Qa-2 null BMDCs, indicating that IFN-γ production was correlated to the expression level of Qa-2 on the BMDCs (Fig 7C) . Since Qa- (Fig 7E) . This suggested the existence of Mtb-specific Qa-2-restricted T cells in B6 mice following Mtb infection.
The expanded CD8 + T cells after Mtb infection include Qa-2-restricted T cells
MR1-restricted T cells do not constitute a significant proportion of MHC Ib-restricted T cells in K b-/-D b-/-M3 -/-mice after Mtb infection
A recent study showed that MR1 -/-mice had higher bacterial load in the lung compared to wild-type mice after BCG infection [26] , suggesting a role for MAIT cells during mycobacteria infection. In addition, MAIT cells were found to be highly enriched in the bronchoalveolar lavage fluid of patients with active TB [49] . Although we did not detect significant number of Mtb-specific MR1-restricted T cells when we stimulated CD8 + T cells from Mtb-infected
-/-mice with Mtb-infected BMDCs (Fig 7B) , it remains possible that in vitro Mtbinfected BMDCs do not contain sufficient amounts of MR1 ligands. To address this issue, culture supernatants from logarithmic phase of Mtb culture (Mtb sup) were used as antigen(s) since they contain vitamin B metabolites known to activate MAIT cells [38, 50] . As both CD8 ing, no significant differences in the expression of Vα19-Jα33 mRNA, the canonical TCR α chain of MAIT cells [52] , were detected in the lungs, spleens and mediastinal lymph nodes at day 30 after Mtb infection, compared to naïve mice (Fig 8B) . Furthermore, unlike MAIT cells, which preferentially use Vβ6 or Vβ8, MHC Ib-restricted CD8 + T cells found in Mtb-infected
-/-mice use diverse TCR Vβ chains (Fig 8C) . Taken together, our data suggest that mice. In fact, we found a substantial fraction of these Mtb-specific unconventional CD8 + T cells were restricted by Qa-2, which is known to present a more diverse array of peptides than other MHC Ib molecules [53] . Qa-2-restricted T cell responses have been implicated in antitumor immunity [48] and antiviral immunity [37] [54] . However, this is the first study to describe a role for Qa-2 in host defense against bacterial infection. As HLA-G is a possible functional homolog of Qa-2 [55] , it will be of great interest to explore whether HLA-G- [31, 56] . Our labs and others have shown that MHC class Ib-restricted CD8 + T cells rapidly respond to Listeria infection [57, 58] . Similarly, during Mtb infection, though the frequency of
-/-mice was much lower than that in naïve B6 mice, we eventually detected similar number of effector CD8 + T cells (Fig 2B) . In addition, we detected comparable number of IFN-γ-producing CD8 + T cells (Fig 3C) between Mtb-infected Memory-like CD44 hi CD8 + T cells [39] and innate-like T cells [40] have been shown to be activated either through the engagement of TCR with microbial antigens or cytokine-driven signals during infection. Some of the Mtb antigens used in our study could enhance the production of inflammatory cytokines by BMDCs in part through the MyD88-dependent pathway (S5 Fig) . Mtb antigens in a TAP-independent manner, similar to HLA-E in humans [29, 30, 59] . However, it is not clear whether the TAP-independent pathway is preferentially used by Mtbinfected cells presenting antigens to MHC Ib-restricted CD8 + T cells in vivo.
In an effort to further define the role of Qa-2 during Mtb infection, we infected two substrains of BALB/c mice, BALB/cJ (Qa-2-sufficient) and BALB/cByJ (Qa-2-deficient), with Mtb and compared the bacterial burden and Mtb-specific T cell responses between these two substrains. We found that BALB/cByJ mice lacked Mtb-specific Qa-2-restricted CD8 + T cells and had a higher bacterial burden in the spleen compared to BALB/cJ mice (S6 Fig). These results suggest that Mtb-specific Qa-2-restricted CD8 + T cells contribute to protection against Mtb infection. However, it is known that BALB/cByJ and BALB/cJ mice have additional genetic differences besides Qa-2 expression. Thus, further experiments involving Qa-2 knockout mice in the B6 background (this mouse strain is yet to be generated) are needed to definitively confirm the role of Qa-2-restricted CD8 + T cells during Mtb infection.
In summary, TB remains a challenge for human health and protective cellular immunity is extremely desirable for the design of better Mtb vaccines. 
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Animal Care and Use Committee of the Northwestern University (Protocol number: IS00000985). [56] , and CD1d -/- [61] on the B6 background mice were generated or maintained in house. C57BL/6, BALB/cJ, BALB/cByJ, TAP 
Mtb fractions and antigens
Mtb fractions and recombinant Mtb proteins (CFP10, PstS1, Ag85A, Ag85B, Ag85C, MPT32 and ESAT6) were obtained through BEI Resources (Manassas, Virginia). Mtb fractions and antigens were dissolved in either DMSO or PBS and stored as aliquots at -20°C.
Mtb aerosol infection and CFU counting
For Mtb aerosol infection, frozen aliquots of Mtb H37Rv were thawed and diluted in PBS with 0.05% Tween 80. Mice were infected with 100-200 CFU using a nose-only aerosol exposure chamber (In-Tox Products, NM), equipped with a Lovelace nebulizer, as previously described [24] . A day 1 count was performed to determine the infecting dose. At indicated time-points after infection, bacterial loads in lungs and spleens were determined by plating serial dilutions of homogenate on Middlebrook 7H11 agar plates (BBL, BD), and colonies were counted after 2-3 weeks of incubation at 37°C.
Primary cell preparation and dendritic cell generation
Single-cell suspensions were prepared from the lung, spleen and mediastinal lymph node by mechanical disruption in HBSS/2% FBS. Lung was digested with collagenase IV (1mg/ml) and DNase I (30μg/ml) for 30 min at 37°C before disruption. To enrich CD8 + T cells, splenocytes and lung leukocytes were labeled with biotinylated mAb specific to CD19 (6D5), CD4 (GK1.5), CD11b (M1/70), CD49b (DX5), TCRγδ (GL-3) and I-A/I-E b (M5/114.15.2) (Biolegend, San Diego, CA) followed by streptavidin-conjugated magnetic beads (Dynabeads, Invitrogen). The purity and composition of enriched CD8 + T cells were confirmed by flow cytometry. Bone marrow-derived dendritic cells (BMDCs) were derived from mouse bone marrow progenitors using GM-CSF and IL-4 (PeproTech, Rocky Hill, NJ) as previously described [56] .
In vitro infection of BMDCs with Mtb H37Rv
BMDCs were plated in 96-well flat-bottom plate at a centration of 1x10 5 cells/well and infected at a multiplicity of 1 or 3 with Mtb for 2h at 37°C. Cultures were washed three times and treated with 20 μg/ml gentamycin for 2 h to remove extracellular bacteria. Enriched CD8 + T cells from Mtb-infected mice were added 24h later to the indicated wells for co-culture. To determine bacterial uptake, some BMDCs were lysed with sterile distilled water containing 0.01% SDS and plated on 7H11 plate.
Antibodies and flow cytometry
Monoclonal antibodies against mouse CD8α (53-6.7), CD8β (YTS156.7.7), CD44 (1M7), CD62L (MEL14), CD127 (A7R34), PD-1 (29F.1A12), KLRG1 (2F1/KLRG1), B220 (RA36B2), CD4 (GK 1.5), TCRβ (H57-597), Gr-1 (1A8), NK1.1 (PK136), anti-Qa-2 (1-1-2), Vβ2 (B20.6), Vβ3 (KJ25), Vβ4 (KT4), Vβ5.1/5.2 (MR9-4), Vβ6 (RR4-7), Vβ7 (TR310), Vβ8.1/8.2 (MR5-2), Vβ8.3 (1B3.3), Vβ9 (MR10-2), Vβ10 (B21.5), Vβ11 (RR3-15), Vβ12 (MR11.1), and Vβ13 (MR12-3) with different fluorochrome conjugate, were purchased either from BioLegend or eBioscience or BD Bioscience (San Diego, CA). Anti-Qa-2 mAb (20-8-4) was purified from hybridoma culture supernatant using the protein A column. For cell surface staining, cells were incubated with 2.4G2 Fcγ RII/RIII blocking mAb for 15 min, then stained with the appropriate combinations of mAbs in HBSS/2% FBS for 30 min at 4°C. Flow cytometry was performed with a FACS CantoII (BD Biosciences, San Jose, CA) and analyzed using FlowJo software (Tree Star, Ashland, OR).
Intracellular cytokine staining
T cells or CD8 + T cells from the spleen and lung of infected mice were stimulated with unpulsed or Mtb antigen-pulsed BMDCs or Mtb-infected BMDCs. After two hours of incubation, Brefeldin A (10μg/ml, Sigma, St. Louis, MO) was added and cells were cultured for additional 16 hours. After incubation period, cells were harvested, stained for cell surface markers, fixed with 4% paraformaldehyde, permeabilized with 0.2% saponin and stained with APC-conjugated anti-IFN-γ (eBioscience), FITC-conjugated anti-TNFα (Biolegend) and PE-conjugated anti-IL-2 mAbs (eBioscience). Flow cytometry was performed as described earlier.
ELISPOT assay
IFN-γ Elispot assay was performed as previously described [24] , with some modifications. Briefly, multiscreen-IP plates (Millipore, Bedford, MA) were coated with anti-IFN-γ mAb (An-18, eBioscience) at 5μg/ml in PBS. BMDCs were pre-pulsed with Mtb fractions or recombinant protein antigens overnight. In a blocking assay, Mtb antigen-pulsed BMDCs were pre-incubated with mouse IgG or anti-Qa-2 mAb (20-8-4) /well) in RPMI 10 medium and plated in triplicate wells. After 18h incubation at 37°C, plates were washed using PBS-Tween (PBS and 0.05% Tween 20) and incubated for 2h at room temperature with biotinylated anti-IFN-γ mAb (R4.6A2, eBioscience). Plates were then washed and incubated with streptavidin-conjugated alkaline phosphatase (Jackson ImmunoResearch Laboratories, West Grove, PA). After 1 h incubation at room temperature, plates were developed with a BCIP/NBT substrate kit (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. Spots were counted using an ImmunoSpot reader (Cellular Technology, Shaker Heights, OH).
In vivo depletion of CD8 + T cells
Mice were given 100 μg of anti-CD8β mAb (53-5.8) or normal rat IgG (controls) by the i.p. route on days -3, 0, 7, 14, and 21 post infection with Mtb, as described by Wang et al. [65] . Mice were killed on day 28 post infection and the depletion efficiency was determined by flow cytometry.
Quantitative RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen), and first-strand cDNA was synthesized using the Superscript III reverse transcriptase (Invitrogen) according to the manufacturer's instructions. Real-time PCR was performed by using IQ5 instrument (Bio-Rad systems). The expression of Vα19-Jα33 transcripts was quantified using primer pairs: Vα19F, 5'-GGTA CAGTTACCTGCTTCTGAC-3', and Jα33R, 5'-GATAGTTGCTATCCCTCACAGC-3' [52] , and the results were normalized to TCRα constant region mRNA.
Statistical analysis
Statistical analysis was performed with GraphPad Prism software (GraphPad, La Jolla, CA). When comparing experimental values from two groups of mice, one-or two-tailed student's ttests were routinely used. When comparing experimental values from multiple groups, twoway ANOVA Bonferroni post-tests were used. Statistically significant differences are noted ( ÃÃÃ P < 0.001; ÃÃ P < 0.01; Ã P < 0.05).
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